Zura Bio Limited · NASDAQ:ZURA
Great Point Partners LLC reported a 5.18% stake in Zura Bio Limited (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Great Point Partners LLC reported a 5.18% stake in Zura Bio Limited, 3,815,930 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 5.18%
- Shares
- 3,815,930
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Great Point Partners, LLC | 5.18% | 3,815,930 |
| Dr. Jeffrey R. Jay, M.D. | 5.18% | 3,815,930 |
| Ms. Lillian Nordahl | 5.18% | 3,815,930 |
Source
Related
- Zura Bio Limited
- Great Point Partners LLC
- Zura Bio Limited shareholders
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026
- Schedule 13G/A · Great Point Partners LLC · Nov 14, 2025
- Schedule 13G · Great Point Partners LLC · May 14, 2025
- Schedule 13G/A · Great Point Partners LLC · Feb 14, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026
- Schedule 13G/A · Montanova Capital, LLC · May 12, 2026
- Schedule 13G/A · JPMorgan Chase & Co · May 6, 2026
- Schedule 13D/A · AI Biotechnology LLC · Mar 2, 2026
- Schedule 13G/A · Montanova Capital, LLC · Feb 13, 2026